SCHEDULE 13G

Company

NYMOX PHARMACEUTICAL CORP

Filed

March 31, 2010

Accession Number

0001374680-10-000003

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →